Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Mehta

Showing results (1071-1080 of 1,216) with videos related to

Pageof 122
Sort By:
Neuro-Oncology|February 12, 2011
Clinical trial end points for high-grade glioma: the evolving landscapeDavid A Reardon, Evanthia Galanis, John F DeGroot, et al.
Journal of Neuro-Oncology|October 9, 2017
Phase I study of sorafenib and tipifarnib for recurrent glioblastoma: NABTC 05-02Phioanh Leia Nghiemphu, Victoria Asuquo Ebiana, Patrick Wen, et al.
International Journal of Radiation Oncology, Biology, Physics|November 4, 2008
Motexafin gadolinium combined with prompt whole brain radiotherapy prolongs time to neurologic progression in non-small-cell lung cancer patients with brain metastases: results of a phase III trialMinesh P Mehta, William R Shapiro, See C Phan, et al.
Neuro-Oncology Advances|November 29, 2023
NRG/RTOG 0837: Randomized, phase II, double-blind, placebo-controlled trial of chemoradiation with or without cediranib in newly diagnosed glioblastomaTracy T Batchelor, Minhee Won, Arnab Chakravarti, et al.
Journal of Neuro-Oncology|December 4, 2009
The role of steroids in the management of brain metastases: a systematic review and evidence-based clinical practice guidelineTimothy C Ryken, Michael McDermott, Paula D Robinson, et al.
Journal of Neuro-Oncology|December 5, 2009
The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guidelineMark E Linskey, David W Andrews, Anthony L Asher, et al.
Journal of Neuro-Oncology|December 5, 2009
The role of surgical resection in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guidelineSteven N Kalkanis, Douglas Kondziolka, Laurie E Gaspar, et al.
International Journal of Radiation Oncology, Biology, Physics|May 7, 2023
Sustained Preservation of Cognition and Prevention of Patient-Reported Symptoms With Hippocampal Avoidance During Whole-Brain Radiation Therapy for Brain Metastases: Final Results of NRG Oncology CC001Vinai Gondi, Snehal Deshmukh, Paul D Brown, et al.
Neuro-Oncology|February 21, 2018
Short delay in initiation of radiotherapy for patients with glioblastoma-effect of concurrent chemotherapy: a secondary analysis from the NRG Oncology/Radiation Therapy Oncology Group databaseDeborah T Blumenthal, Minhee Won, Minesh P Mehta, et al.
Journal of Neuro-Oncology|December 4, 2009
The role of prophylactic anticonvulsants in the management of brain metastases: a systematic review and evidence-based clinical practice guidelineTom Mikkelsen, Nina A Paleologos, Paula D Robinson, et al.
Pageof 122

Showing results (1071-1080 of 1,216) with videos related to

Sort By:
Pageof 122
Neuro-Oncology|February 12, 2011
Clinical trial end points for high-grade glioma: the evolving landscapeDavid A Reardon, Evanthia Galanis, John F DeGroot, et al.
Journal of Neuro-Oncology|October 9, 2017
Phase I study of sorafenib and tipifarnib for recurrent glioblastoma: NABTC 05-02Phioanh Leia Nghiemphu, Victoria Asuquo Ebiana, Patrick Wen, et al.
International Journal of Radiation Oncology, Biology, Physics|November 4, 2008
Motexafin gadolinium combined with prompt whole brain radiotherapy prolongs time to neurologic progression in non-small-cell lung cancer patients with brain metastases: results of a phase III trialMinesh P Mehta, William R Shapiro, See C Phan, et al.
Neuro-Oncology Advances|November 29, 2023
NRG/RTOG 0837: Randomized, phase II, double-blind, placebo-controlled trial of chemoradiation with or without cediranib in newly diagnosed glioblastomaTracy T Batchelor, Minhee Won, Arnab Chakravarti, et al.
Journal of Neuro-Oncology|December 4, 2009
The role of steroids in the management of brain metastases: a systematic review and evidence-based clinical practice guidelineTimothy C Ryken, Michael McDermott, Paula D Robinson, et al.
Journal of Neuro-Oncology|December 5, 2009
The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guidelineMark E Linskey, David W Andrews, Anthony L Asher, et al.
Journal of Neuro-Oncology|December 5, 2009
The role of surgical resection in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guidelineSteven N Kalkanis, Douglas Kondziolka, Laurie E Gaspar, et al.
International Journal of Radiation Oncology, Biology, Physics|May 7, 2023
Sustained Preservation of Cognition and Prevention of Patient-Reported Symptoms With Hippocampal Avoidance During Whole-Brain Radiation Therapy for Brain Metastases: Final Results of NRG Oncology CC001Vinai Gondi, Snehal Deshmukh, Paul D Brown, et al.
Neuro-Oncology|February 21, 2018
Short delay in initiation of radiotherapy for patients with glioblastoma-effect of concurrent chemotherapy: a secondary analysis from the NRG Oncology/Radiation Therapy Oncology Group databaseDeborah T Blumenthal, Minhee Won, Minesh P Mehta, et al.
Journal of Neuro-Oncology|December 4, 2009
The role of prophylactic anticonvulsants in the management of brain metastases: a systematic review and evidence-based clinical practice guidelineTom Mikkelsen, Nina A Paleologos, Paula D Robinson, et al.
Pageof 122